Principal Financial Group Inc. Has $6.88 Million Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

Principal Financial Group Inc. boosted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 2.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 221,896 shares of the company’s stock after buying an additional 4,963 shares during the period. Principal Financial Group Inc. owned approximately 0.44% of Astrana Health worth $6,881,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Illumine Investment Management LLC bought a new stake in Astrana Health during the first quarter worth about $566,000. City Center Advisors LLC acquired a new position in shares of Astrana Health in the first quarter valued at approximately $276,000. E. Ohman J or Asset Management AB increased its stake in shares of Astrana Health by 85.8% in the first quarter. E. Ohman J or Asset Management AB now owns 61,300 shares of the company’s stock valued at $1,901,000 after buying an additional 28,300 shares during the period. GAMMA Investing LLC raised its holdings in Astrana Health by 5,794.8% during the 1st quarter. GAMMA Investing LLC now owns 12,497 shares of the company’s stock worth $403,000 after purchasing an additional 12,285 shares during the last quarter. Finally, PharVision Advisers LLC bought a new position in Astrana Health during the 4th quarter worth approximately $211,000. Institutional investors own 52.77% of the company’s stock.

Wall Street Analysts Forecast Growth

ASTH has been the subject of several recent analyst reports. Barclays initiated coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price objective for the company. Truist Financial cut their price objective on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and a consensus target price of $53.29.

Astrana Health Price Performance

NASDAQ ASTH opened at $24.49 on Wednesday. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of 34.01, a PEG ratio of 0.92 and a beta of 0.84. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.70 and a current ratio of 1.70. The stock has a 50-day moving average of $25.69 and a 200 day moving average of $30.30. Astrana Health, Inc. has a one year low of $23.12 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.09). The company had revenue of $620.39 million for the quarter, compared to analysts’ expectations of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The firm’s quarterly revenue was up 53.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.31 earnings per share. On average, sell-side analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.